bioXXmed AG

XTRA:T5O Stok Raporu

Piyasa değeri: €1.5m

bioXXmed Yönetim

Yönetim kriter kontrolleri 0/4

We currently do not have sufficient information about the CEO.

Anahtar bilgiler

Mark-André Freyberg

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesin/a
CEO görev süresi24.8yrs
CEO sahipliğin/a
Yönetim ortalama görev süresiVeri yok
Yönetim Kurulu ortalama görev süresiVeri yok

Son yönetim güncellemeleri

Güncelleme yok

Recent updates

Is CytoTools (ETR:T5O) In A Good Position To Invest In Growth?

Jul 29
Is CytoTools (ETR:T5O) In A Good Position To Invest In Growth?

CytoTools AG (ETR:T5O): Are Analysts Optimistic?

May 12
CytoTools AG (ETR:T5O): Are Analysts Optimistic?

Loss-Making CytoTools AG (ETR:T5O) Expected To Breakeven In The Medium-Term

Jan 08
Loss-Making CytoTools AG (ETR:T5O) Expected To Breakeven In The Medium-Term

CEO

Mark-André Freyberg

24.8yrs

Görev süresi

Dr. Mark-Andr? Freyberg co-founded bioXXmed AG (formerly known as CytoTools AG) in 2000 and serves as Chief Executive Officer since 2000 and had been the Chairman of Management Board until September 30, 20...